Thursday, 26 November 2020

Study is the first to link microbiota to dynamics of the human immune system

Memorial Sloan Kettering Cancer Center researchers have uncovered an important finding about the relationship between the microbiota and the immune system, showing for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut.

Embryonic stem cells have their own strategy for protecting chromosome ends

According to new research from CCR scientists, embryonic stem cells have a unique way of protecting their telomeres, the structures at the ends of chromosomes that shorten with every cell division. A research team led by Eros Lazzerini Denchi, Ph.D., an NIH Stadtman investigator in CCR's Laboratory of Genomic Integrity, has found that rather than treating exposed telomeres as damaged DNA as most cells do, embryonic stem cells call on genes typically used only during the earliest stage of development to stave off unwanted DNA repair. The team's findings, which come from studies of mouse embryonic stem cells, are reported November 25, 2020, in Nature.

Protein commonly screened for in pregnancy is linked to gestational diabetes

Laboratory research and analysis of epidemiological data by Silvia Corvera, MD, and Tiffany Moore Simas, MD, MPH, MEd, and colleagues show that low levels of a protein commonly seen in screening tests for chromosomal disorders during the first trimester of pregnancy is associated with adipose tissue remodeling, glucose resistance and gestational diabetes mellitus in pregnant women. The study, published in Science Translational Medicine, outlines a new role for pregnancy-associated plasma protein A, known as PAPPA, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target.

COVID-19: Twelve key milestones in a year like no other

From the first cases in central China to hopes of a vaccine a year later, here are a dozen key developments in the spread and subsequent fight against COVID-19.

After year-long sprint, COVID-19 vaccines finally at hand

Less than a year after an unknown coronavirus that has claimed 1.4 million lives began spreading across the globe, a number of highly promising COVID-19 vaccines are on the cusp of release.

'Infodemic' risks jeopardising virus vaccines

As early as February, with the global pandemic spreading fast, the World Health Organization issued a warning about an "infodemic", a wave of fake news and misinformation about the deadly new disease on social media.

A different 'super spreader': Facebook struggles with election disinfo

The US presidential election is finished: votes cast, the transition—though delayed—begun.

Over 2,400 US COVID deaths in 24 hours, a six-month high

The United States on Wednesday registered more than 2,400 deaths from COVID-19 in 24 hours, according to the Johns Hopkins University tally—the highest daily toll in six months as the Thanksgiving holiday began.

Narcolepsy fiasco spurs COVID vaccine fears in Sweden

Take a vaccine developed in haste? Never again, says Meissa Chebbi, who, like hundreds of other young Swedes suffered debilitating narcolepsy after a mass vaccination campaign against the 2009-2010 swine flu pandemic.

LatAm governments facing vaccine distribution challenges

Cash-strapped Latin American governments face severe geographical, economic and social challenges in trying to ensure life-saving COVID-19 vaccines are made available to vulnerable populations, experts say.

South Korea virus cases hit highest level since March

South Korea reported its highest daily number of coronavirus cases since March on Thursday, with a surge of new infections sparking fears of a major third wave.

Pandemic postpones national math, reading tests until 2022

National reading and math tests long used to track what U.S. students know in those subjects are being postponed from next year to 2022 over concerns about whether testing would be feasible or produce valid results during the coronavirus pandemic, the National Center for Education Statistics announced Wednesday.

California records new high in coronavirus cases

California reported a record number of coronavirus cases Wednesday as Los Angeles restaurants prepared to close for three weeks and firefighters in Silicon Valley were being enlisted to help enforce public health rules to try to halt the spread of infections.

High blood pressure in midlife is linked to increased brain damage in later life

Higher than normal blood pressure is linked to more extensive brain damage in the elderly, according to a new study published today in the European Heart Journal.

Fiji's vaccine program reduces childhood death and illness: study

Fiji's national vaccine program against pneumonia, a serious lung condition, and rotavirus, a common disease which causes severe diarrhoea and vomiting, has reduced illness and death, new research shows.

Scientists develop new gene therapy for eye disease

Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe.

Understanding traditional Chinese medicine can help protect species

Demystifying traditional Chinese medicine for conservationists could be the key to better protecting endangered species like pangolins, tigers and rhino, according to University of Queensland-led researchers.

Mass evacuations hailed for casualty-free India cyclone

Accurate forecasting and the evacuation of several hundred thousand people helped avert any loss of life after a cyclone clobbered southeast India, authorities said Thursday, as rescuers worked to restore power and clear fallen trees.

Coronavirus treatments: some progress, no panacea

Nearly a year after a mysterious pneumonia emerged in China and began its global spread, there is still no silver bullet treatment for COVID-19 despite an unprecedented effort to discover new medicines or repurpose existing drugs.